MINNEAPOLIS, Sept. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced the Company received an expected notice (the "First Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, due to the Company's failure to timely file its Form 10- Q f ...

MINNEAPOLIS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data (RWD), has announced that Bob Golden has joined the OneMedNet Executive Team as Chief Financial Officer spearheading all aspects of the company's financial and accounting operations while continuing to serve as a member of the Board of Directors. Mr. Golden is a Certified Public Accountant with more than 40 years of experience. Mr. Golde ...

MINNEAPOLIS, Aug. 09, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data (RWD), has successfully integrated its proprietary AI technology into its data curation process, ensuring rapid and precise de-identification of patient data. This innovation, coupled with other changes undertaken by the Company, has significantly reduced OneMedNet's operational costs, enabling the company to process vast amounts of clini ...

Core Viewpoint - OneMedNet Corporation has successfully completed a private placement, raising approximately $4.6 million, which will be used for working capital and general corporate purposes, including a significant investment in Bitcoin [1][2][3]. Group 1: Private Placement Details - The private placement involved securities purchase agreements with institutional investors, including Off the Chain Capital and Discovery Capital Management [1]. - OneMedNet sold 1,297,059 shares at $1.0278 per share and prefunded warrants for 1,323,530 shares at the same price to Off the Chain Capital [2]. - The company also sold 2,301,791 shares at $0.85 per share to Discovery Capital Management [3]. Group 2: Use of Proceeds - The net proceeds from the private placement will primarily be allocated for working capital and general corporate purposes [1]. - The company has already utilized $1.8 million of the net proceeds to purchase Bitcoin [1]. Group 3: Company Overview - OneMedNet Corporation specializes in curating regulatory-grade Real World Data (RWD), including electronic health records, laboratory results, and medical imaging [6]. - The company operates the iRWD™ platform, which manages diverse clinical data types and supports research opportunities for drug, medical device, and AI development customers [6][7]. - OneMedNet's platform is designed to meet clinical requirements across various domains, including rare diseases, oncology, and cardiology [7].

About OneMedNet Corporation OneMedNet provides innovative solutions that unlock the significant value contained within the Real-World Data ("RWD") repositories of over 1,400 healthcare system and provider sites that currently comprise its iRWD™ network. OneMedNet's proprietary iRWD™ platform provides secure, comprehensive management of diverse clinical data types, including electronic health records, laboratory results, and uniquely, medical imaging. Employing its robust iRWD™ platform, the Company securely ...

MINNEAPOLIS, July 22, 2024 (GLOBE NEWSWIRE) -- Further to its press release dated June 14, 2024, OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, announced today that Cytel Inc, ("Cytel"), a global leader in clinical trial design and software, has now identified itself as the other party with which OneMedNet recently entered into a iR ...

MINNEAPOLIS, July 22, 2024 (GLOBE NEWSWIRE) -- Further to its press release dated June 14, 2024, OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, announced today that Cytel Inc, ("Cytel"), a global leader in clinical trial design and software, has now identified itself as the other party with which OneMedNet recently entered into a iRW ...

Core Insights - OneMedNet Corporation has entered into a data license agreement with a leading U.S.-based company in clinical trial design, enhancing its market expansion strategy and commercial reach in the life sciences industry [1][2][6] - The partnership aims to leverage OneMedNet's proprietary iRWD™ platform, which manages a diverse set of clinical data, to accelerate the development of new medical therapies and technologies [2][6] - OneMedNet's iRWD™ network includes data from over 1,400 healthcare systems and provider sites, providing significant research opportunities for drug, medical device, and imaging/diagnostic AI development [2][6][8] Company Overview - OneMedNet specializes in regulatory-grade Real World Data (RWD), including electronic health records, laboratory results, and medical imaging [1][2] - The company is committed to enhancing patient outcomes and supporting healthcare innovation across various domains, including rare diseases, oncology, and cardiology [8] - The iRWD™ platform is designed to securely de-identify, search, and curate clinical data, creating a robust funnel of business opportunities for its clients [2][6]

"This partnership aligns perfectly with OneMedNet's market expansion strategy, and significantly extends our commercial reach within the global life science industry," said Aaron Green, OneMedNet's President and CEO. "Our new partner's recognized expertise in clinical trial design and implementation, combined with our innovative RWD platform, creates a powerful synergy that should help accelerate the development of innovative new medical therapies and technologies targeting some of the world's greatest heal ...

MINNEAPOLIS, June 06, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and medical imaging, is pleased to announce that it has joined the Amazon Web Services ("AWS") Partner Network ("APN") and secured a significant new iRWD™ client, an undisclosed computational biotechnology organization, via the AWS Marketplace. About OneMedNet Corporation ...